ArticleBlood advances2020

Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome.

Je-Hwan Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.